ENTA
#3068
Enanta Pharmaceuticals, Inc. - Common Stock
13.5 1 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.35%
Changement Mensuel
+6.38%
Evolution sur 6 mois
-6.70%
Changement Annuel
+49.12%
Clôture Précédente
13.3 3
Open
13.5 1
Low
13.5 1
High
13.5 1
Volume
42
Financials
- Market Capitalization 393.48 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.02
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3051 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.07 USD | +0.74% | -2.16% | +1.50% | +37.04% | 403.53 M USD | ||
| 3064 |  EYPT EyePoint, Inc. - Common Stock | 4.58 USD | +1.78% | -8.76% | -62.88% | -61.83% | 394.85 M USD | ||
| 3088 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.70 USD | -1.26% | -7.84% | +13.25% | -1.88% | 385.62 M USD | ||
| 3097 |  CTNM Contineum Therapeutics, Inc. - Common stock | 16.55 USD | +1.91% | -2.53% | +8.74% | +8.38% | 382.29 M USD |